Ambagon Therapeutics raised €75M in a Series A round in Jan 2022. The company is based in Eindhoven, Netherlands. Investors in the round: AbbVie Ventures, Droia Ventures, Inkef Capital and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
